1. Chile Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Clínica Las Condes S.A.

Clínica Las Condes S.A.

LAS-CONDES.SN
Clínica Las Condes S.A.CL flagSantiago Stock Exchange
11,400.00
CLP
+321.00
- -
116.25BMarket Cap
Clínica Las Condes S.A.
LAS-CONDES.SN
(Santiago Stock Exchange)

Recent

price

11,400.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8,050.27
8,731.09
9,570.25
10,419.74
11,729.83
13,357.83
14,618.5
14,471.48
16,288.97
16,793.36
15,759.32
20,554.56
19,302.66
15,016.65
12,679.06
10,159.44
10,871.13
Revenue per Share
1,096.31
1,187.69
1,244.62
1,358.59
1,067.1
395.36
111.58
-768.13
334.44
387.51
-391.99
1,367.32
300.44
-652.21
-8,904.19
-4,026.25
-2,998.07
Basic EPS, GAAP
- -
- -
-1,487.07
-3,413.61
-3,656.2
-2,034.93
-2,059.23
-1,879.98
-445.74
-327.1
-311.83
-571.77
-891.53
-415.62
-119.63
-32.1
-50.74
Free Cash Flow per Basic Share
456.67
547.23
591.31
621.42
677.67
547.23
333.56
32.92
- -
100.33
116.25
- -
410.2
90.14
- -
- -
- -
Dividend per Share
9,897.7
10,516.74
11,195.75
11,837.66
11,738.16
11,716.18
11,545.34
10,811.47
10,517.07
10,788.33
10,492.04
11,431.58
11,642.85
10,990.58
1,901.79
156.17
-239.48
Book Value per Share
9,996.67
10,615.48
11,294.15
11,887.85
11,777.95
11,762.34
10,706.87
10,132.12
9,945.63
10,243.27
18,361.59
19,163.91
19,374.95
18,911.54
10,901.24
11,814.61
11,539.94
Tangible Book Value per Share
13
13
13
13
13
13
13
13
13
13
13
13
13
13
12
16
16
Basic Weighted Avg Shares
106,908
115,949
127,363
138,851
156,386
178,054
196,473
194,920
219,400
226,194
212,266
276,854
259,992
202,263
153,388
165,196
174,905
Sales/Revenue/Turnover
17.98
18.32
17.79
17.38
13.04
7.98
5.19
-3.08
9.2
7.9
3.11
15.12
10.51
0.14
-38.11
-41.18
-24.25
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
1,638
1,584
1,680
1,608
1,925
2,527
8,788
9,603
8,312
8,115
Depreciation Expense
14,559
15,773
16,564
18,104
14,227
5,270
1,500
-10,346
4,505
5,219
-5,280
18,417
4,047
-8,785
-107,721
-65,468
-48,236
Net Income, GAAP
15.25
19.38
22.01
19.65
9.76
20.29
5.11
- -
- -
7.33
- -
15.91
- -
- -
- -
- -
- -
Effective Tax Rate (%)
13.62
13.6
13.01
13.04
9.1
2.96
0.76
-5.31
2.05
2.31
-2.49
6.65
1.56
-4.34
-70.23
-39.63
-27.58
Profit Margin (%)
43,745
43,692
44,684
51,080
36,440
35,001
61,639
26,854
74,022
83,054
74,465
95,314
69,370
50,933
-90,150
-52,907
-59,476
Working Capital
17,795
21,524
27,832
67,366
96,049
110,490
145,688
146,336
198,013
202,809
187,184
183,590
163,078
159,090
152,691
239,884
240,910
LT Debt
132,991
141,233
150,566
159,439
158,190
157,865
156,862
149,317
145,625
148,039
256,520
268,051
270,776
261,691
136,587
194,509
187,736
Total Equity
10.89
10.66
10.12
9.39
7.47
4.11
3.14
- -
- -
4.68
- -
7.52
- -
- -
- -
- -
- -
Return on Invested Capital (%)
10.87
10.9
10.33
9.41
6.38
3.12
2.37
- -
- -
3.76
- -
7.1
- -
- -
- -
- -
- -
Return on Capital (%)
11.55
11.64
11.48
11.8
9.05
3.37
0.96
-6.88
3.14
3.64
-3.68
12.47
2.6
-5.76
-125.96
-512.54
-701.14
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
78,407
32,637
64,004
LT Borrowings
152,688
239,700
240,741
LT Finance Leases
- -
184
169
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
235,178
235,222
212,374

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
156,263
94,878
107,443
Cash, Cash Equivalents & STI
24,916
27,106
35,022
Accounts Receivable, Net
43,193
106,202
- -
Inventories
3,157
3,162
3,055
Total Current Liabilities
191,831
147,785
166,919
Payables & Accruals
- -
- -
- -
ST Debt
78,407
32,637
64,004
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.38%
-0.65%
42.41%
Free Cash Flow
-16.62%
-10.44%
-63.93%
Net Income, GAAP
-94.72%
48.62%
-39.22%
Sales/Revenue/Turnover
0.47%
-2.86%
7.7%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
47,952
46,313
38,772
38,064
153,388
2025
36,804
41,151
43,562
43,678
165,196
2026
46,513
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
42.45
-47.34
-1,369.84
- -
-8,904.19
2025
-1,952.8
-572.87
-714.75
- -
-4,026.25
2026
-393.12
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Canadian General Medical Center Complex Company (9518.SR)
I'rom Group Co., Ltd. (2372.T)
PT Medikaloka Hermina Tbk (HEAL.JK)
Elan Corporation (6099.T)
Artemis Medicare Services Limi (ARTEMISMED.BO)
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)
Business
Clínica Las Condes S.A. Clínica Las Condes S.A. (LAS-CONDES.SN) operates private hospital centers in Chile, delivering high-complexity medical services including hospitalization, surgery, intensive and intermediate care units for adults and pediatrics, neonatology, organ transplants, post-operative recovery, clinical laboratories, imaging diagnostics such as radiology, computerized tomography, magnetic resonance imaging, ultrasonography, nuclear medicine, radiotherapy, hemodialysis, and outpatient procedures across all medical specialties like anesthesia, bronchopulmonary, cardiology, internal medicine, oncology, and emergency care. Founded in 1979 and inaugurated in 1982, the company maintains its headquarters in Santiago's Las Condes commune at Estoril 450, with additional facilities in Chicureo, Peñalolén, Valle Nevado, and La Parva, all within Chile's Metropolitan Region, and employs around 2,863 staff through direct and indirect subsidiaries including Diagnosticos por Imagenes Ltda., Servicios de Salud Integrados SA, Prestaciones Medicas Las Condes SA, Inmobiliaria CLC SA, and Seguros CLC SA. Targeting private patients and those covered by Isapres insurance providers such as Cruz Blanca, the firm focuses on comprehensive care with advanced technology and specialized physicians, deriving majority revenue from hospitalization services while expanding outpatient, insurance, and other segments. Recent developments include sustained growth in radiotherapy services through new referral agreements with Oncovida and Clínica Bupa, initiating pediatric complex treatments for FONASA patients, acquisition of land in Peñalolén for a new satellite center, operations at Valle Nevado and La Parva medical centers, signing of a key convenio with Isapre Cruz Blanca, inauguration of a specialized Memory Center for early dementia diagnosis and treatment with interdisciplinary teams and innovative therapies, plans under new administration to add 150 physicians and achieve positive EBITDA by end-2025, and a historic agreement with Isapres resolving prior conflicts.